Position in REGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$111,930,417
+$82,204,639 QoQ
Shares Held
179,508
+366.6% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#74
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KBC Group NV holds $308,329,109 across 107 Biotechnology names. REGN ranks #1 (36.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
179,508 | $111,930,417 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
128,466 | $63,812,914 | |
| 3 | INCY |
Incyte Corp
|
270,882 | $30,707,183 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
98,265 | $23,678,916 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
91,584 | $7,963,228 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
129,010 | $7,787,043 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
127,194 | $7,278,040 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
116,847 | $6,372,835 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,930,417 | 179,508 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $29,725,778 | 38,473 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $29,497,011 | 38,215 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $18,702,224 | 33,262 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $19,200,300 | 36,572 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $94,779,330 | 149,440 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $97,337,756 | 136,647 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $36,214,166 | 34,449 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $36,199,574 | 34,442 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $32,969,131 | 34,254 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $57,551,708 | 65,527 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $54,796,790 | 66,585 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $51,242,679 | 71,315 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $62,320,382 | 75,846 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $78,699,406 | 109,079 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $42,765,049 | 62,080 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $49,380,043 | 83,535 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $60,589,330 | 86,752 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $146,667,993 | 232,246 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $87,349,865 | 144,337 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $73,638,471 | 131,841 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $69,889,401 | 147,714 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $69,699,728 | 144,273 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $72,105,821 | 128,811 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $42,536,048 | 68,205 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $15,802,527 | 32,363 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||